• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form D filed by Sonendo Inc.

    5/12/25 1:21:37 PM ET
    $SONX
    Medical/Dental Instruments
    Health Care
    Get the next $SONX alert in real time by email
    SEC FORM D

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM D

    Notice of Exempt Offering of Securities

    OMB APPROVAL
    OMB Number: 3235-0076
    Estimated average burden
    hours per response: 4.00

    1. Issuer's Identity

    CIK (Filer ID Number) Previous Names
       None
    Entity Type
    0001407973
    Dentatek CORP
    X Corporation
       Limited Partnership
       Limited Liability Company
       General Partnership
       Business Trust
       Other (Specify)

    Name of Issuer
    Sonendo, Inc.
    Jurisdiction of Incorporation/Organization
    DELAWARE
    Year of Incorporation/Organization
    X Over Five Years Ago
       Within Last Five Years (Specify Year)
       Yet to Be Formed

    2. Principal Place of Business and Contact Information

    Name of Issuer
    Sonendo, Inc.
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode Phone Number of Issuer
    Laguna Hills CALIFORNIA 92653 (949) 766-3636

    3. Related Persons

    Last Name First Name Middle Name
    Bergheim Bjarne
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Bostjancic John
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    McGaugh John
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Bihl III Anthony P.
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Beaver Carolyn
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Bergheim Olav
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Pudipeddi Raj
    Street Address 1 Street Address 2
    26061 MERIT CIRCLE SUITE 102
    City State/Province/Country ZIP/PostalCode
    LAGUNA HILLS CALIFORNIA 92653
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    4. Industry Group

       Agriculture
    Banking & Financial Services
       Commercial Banking
       Insurance
       Investing
       Investment Banking
       Pooled Investment Fund
    Is the issuer registered as
    an investment company under
    the Investment Company
    Act of 1940?
       Yes    No
       Other Banking & Financial Services
       Business Services
    Energy
       Coal Mining
       Electric Utilities
       Energy Conservation
       Environmental Services
       Oil & Gas
       Other Energy
    Health Care
       Biotechnology
       Health Insurance
       Hospitals & Physicians
       Pharmaceuticals
    X Other Health Care
       Manufacturing
    Real Estate
       Commercial
       Construction
       REITS & Finance
       Residential
       Other Real Estate
      
    Retailing
      
    Restaurants
    Technology
       Computers
       Telecommunications
       Other Technology
    Travel
       Airlines & Airports
       Lodging & Conventions
       Tourism & Travel Services
       Other Travel
      
    Other

    5. Issuer Size

    Revenue Range OR Aggregate Net Asset Value Range
       No Revenues    No Aggregate Net Asset Value
       $1 - $1,000,000    $1 - $5,000,000
       $1,000,001 - $5,000,000    $5,000,001 - $25,000,000
       $5,000,001 - $25,000,000    $25,000,001 - $50,000,000
       $25,000,001 - $100,000,000    $50,000,001 - $100,000,000
       Over $100,000,000    Over $100,000,000
    X Decline to Disclose    Decline to Disclose
       Not Applicable    Not Applicable

    6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

       Rule 504(b)(1) (not (i), (ii) or (iii))
       Rule 504 (b)(1)(i)
       Rule 504 (b)(1)(ii)
       Rule 504 (b)(1)(iii)
    X Rule 506(b)
       Rule 506(c)
       Securities Act Section 4(a)(5)
       Investment Company Act Section 3(c)
       Section 3(c)(1)    Section 3(c)(9)  
       Section 3(c)(2)    Section 3(c)(10)
       Section 3(c)(3)    Section 3(c)(11)
       Section 3(c)(4)    Section 3(c)(12)
       Section 3(c)(5)    Section 3(c)(13)
       Section 3(c)(6)    Section 3(c)(14)
       Section 3(c)(7)

    7. Type of Filing

    X New Notice Date of First Sale 2025-04-30    First Sale Yet to Occur
       Amendment

    8. Duration of Offering

    Does the Issuer intend this offering to last more than one year?
       Yes X No

    9. Type(s) of Securities Offered (select all that apply)

    X Equity    Pooled Investment Fund Interests
       Debt    Tenant-in-Common Securities
       Option, Warrant or Other Right to Acquire Another Security    Mineral Property Securities
       Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security    Other (describe)

    10. Business Combination Transaction

    Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
       Yes X No

    Clarification of Response (if Necessary):

    11. Minimum Investment

    Minimum investment accepted from any outside investor $0 USD

    12. Sales Compensation

    Recipient
    Recipient CRD Number    None
    Brookline Capital Markets 44656
    (Associated) Broker or Dealer    None
    (Associated) Broker or Dealer CRD Number    None
    Arcadia Securities, LLC 44656
    Street Address 1 Street Address 2
    600 Lexington Avenue 30th Floor
    City State/Province/Country ZIP/Postal Code
    New York NEW YORK 10022
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
       Foreign/non-US
    CALIFORNIA
    DELAWARE
    FLORIDA
    NEW YORK
    SOUTH CAROLINA
    TEXAS
    VIRGINIA

    13. Offering and Sales Amounts

    Total Offering Amount $15,000,000 USD
    or    Indefinite
    Total Amount Sold $5,000,000 USD
    Total Remaining to be Sold $10,000,000 USD
    or    Indefinite

    Clarification of Response (if Necessary):

    14. Investors

      
    Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
    Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
    15

    15. Sales Commissions & Finder's Fees Expenses

    Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

    Sales Commissions $234,500 USD
       Estimate
    Finders' Fees $0 USD
       Estimate

    Clarification of Response (if Necessary):

    16. Use of Proceeds

    Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

    $0 USD
       Estimate

    Clarification of Response (if Necessary):

    Signature and Submission

    Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

    Terms of Submission

    In submitting this notice, each issuer named above is:
    • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
    • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
    • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

    Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

    For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

    Issuer Signature Name of Signer Title Date
    Sonendo, Inc. John Bostjancic John Bostjancic Chief Financial Officer 2025-05-12

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

    * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


    Get the next $SONX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SONX

    DatePrice TargetRatingAnalyst
    3/12/2024Buy → Hold
    Stifel
    1/31/2022$6.90Equal-Weight
    Morgan Stanley
    11/23/2021$16.00Buy
    Stifel
    11/23/2021$15.00Buy
    B of A Securities
    11/23/2021$30.00Buy
    Goldman Sachs
    11/23/2021$17.00Overweight
    Piper Sandler
    More analyst ratings

    $SONX
    SEC Filings

    See more
    • SEC Form D filed by Sonendo Inc.

      D - Sonendo, Inc. (0001407973) (Filer)

      5/12/25 1:21:37 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K filed by Sonendo Inc.

      10-K - Sonendo, Inc. (0001407973) (Filer)

      3/26/25 4:06:45 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by Sonendo Inc.

      EFFECT - Sonendo, Inc. (0001407973) (Filer)

      2/28/25 12:15:03 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care

    $SONX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sonendo Inc.

      SC 13G/A - Sonendo, Inc. (0001407973) (Subject)

      11/14/24 4:40:34 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Sonendo Inc.

      SC 13G - Sonendo, Inc. (0001407973) (Subject)

      11/14/24 1:23:43 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Sonendo Inc. (Amendment)

      SC 13G/A - Sonendo, Inc. (0001407973) (Subject)

      2/14/24 5:15:11 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care

    $SONX
    Financials

    Live finance-specific insights

    See more

    $SONX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024

      Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will postpone the third quarter 2024 conference call that was previously scheduled for after the market close on Tuesday, November 12th, 2024. The Company still intends to file its audited financial results on November 12th, 2024, but has postponed, until further notice, the accompanying conference call. Management will provide commentary on events subsequent to the end of the quarter ending September 30th, 2024, at a later date. About Sonendo Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth deca

      11/11/24 4:05:00 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024

      Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the third quarter 2024 after the market close on Tuesday, November 12th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 788725. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be available on th

      10/29/24 4:05:00 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance

      Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Generated $8.3 million total revenue for second quarter of 2024 and carried over a healthy console backlog for the second straight quarter; Drove substantial increases in GAAP gross margin and adjusted gross margins (non-GAAP) to 37.5% and 40.7%, respectively, based primarily on lower manufacturing and console warranty costs; Significantly reduced GAAP operating loss to $6.7 million and adjusted EBITDA (non-GAAP) loss to $5.7 million, a 61% and 55% improv

      8/7/24 4:05:00 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sr. VP Operations Mcgaugh John P. was granted 500,000 shares, increasing direct ownership by 142% to 852,896 units (SEC Form 4)

      4 - Sonendo, Inc. (0001407973) (Issuer)

      9/19/24 5:48:44 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Bostjancic John J. was granted 600,000 shares, increasing direct ownership by 83% to 1,320,000 units (SEC Form 4)

      4 - Sonendo, Inc. (0001407973) (Issuer)

      9/19/24 5:46:24 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • President and CEO Bergheim Bjarne was granted 1,600,000 shares, increasing direct ownership by 85% to 3,488,518 units (SEC Form 4)

      4 - Sonendo, Inc. (0001407973) (Issuer)

      9/19/24 5:42:53 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care

    $SONX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sonendo, Inc. Announces $5.0 Million Private Placement

      Sonendo, Inc. (OTC:SONX) ("Sonendo" or the "Company"), a leading dental technology company and developer of the GentleWave® System, today announced a private placement of common stock, resulting in gross proceeds of $5.0 million (the "Private Placement"). New and existing investors, including certain directors and officers of the Company, participated in the financing. Sonendo intends to use the proceeds from the financing to expand commercial programs to drive revenue growth, continue executing ongoing business restructuring activities to further reduce operating expenses and accelerate the path to positive adjusted EBITDA and operating cash flow, to retain senior leadership and key emplo

      5/1/25 6:00:00 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Sonendo, Inc. (OTC:SONX) ("Sonendo" or the "Company"), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter and year ended December 31, 2024. Quarterly Highlights Generated $8.3 million total revenue for the fourth quarter 2024; Drove substantial 1,570 and 1,260 basis points of GAAP and adjusted (non-GAAP) gross margin expansion for the fourth quarter 2024 to 41.1% and 41.3%, respectively, as compared to the prior year quarter; Significantly reduced GAAP operating loss to $5.6 million and adjusted EBITDA (non-GAAP) loss to $4.7 million for the fourth quarter 2024, an improvement of 45.2% and 45.0%, respectively,

      3/26/25 4:05:00 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sonendo, Inc. Reports Third Quarter 2024 Financial Results

      Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Generated $8.0 million total revenue for the third quarter of 2024 and carried over a double-digit console backlog for the third straight quarter; Drove substantial increases in GAAP gross margin and adjusted gross margins (non-GAAP) to 41.2% and 42.6%, respectively, based primarily on lower manufacturing and console warranty costs; Significantly reduced GAAP operating loss to $7.5 million and adjusted EBITDA (non-GAAP) loss to $5.1 million, a 57% and

      11/12/24 4:05:00 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care

    $SONX
    Leadership Updates

    Live Leadership Updates

    See more
    • Sonendo Strengthens Leadership With Key Strategic Appointments

      John Bostjancic Appointed as Chief Financial Officer Bob Guyatt Appointed as Senior Vice President of Marketing John McGaugh Promoted to Senior Vice President of Operations Sonendo, Inc. (OTCQX:SONX) ("Sonendo"), a leading dental technology company and developer of the GentleWave® System, today announced the appointment of John Bostjancic as Chief Financial Officer, the appointment of Robert Guyatt as Senior Vice President of Marketing, and the promotion of John McGaugh to Senior Vice President of Operations. "Sonendo is embarking on a reset strategy to drive fundamental change within the organization," said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. "We have fil

      6/5/24 4:05:00 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sonendo Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave® Procedure for Elevated Root Canal Treatment

      The Partnership Agreements Aim to Increase the Number of Endodontic Practices Offering the GentleWave System Sonendo, Inc. (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced the signing of two new strategic partnership agreements with the country's leading endodontic dental service organizations (DSOs) to expand patient access to a best-in-class root canal experience. As a result of these partnerships, the GentleWave System with CleanFlow™ Technology, which offers a less invasive and less painful alternative to traditional root canal therapy, will be available in more endodontic offices nationwide. Sonendo previously announced the a

      10/4/23 8:00:00 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08

      Sonendo, Inc. (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that on September 25, 2023, the Compensation Committee of Sonendo's Board of Directors granted restricted stock unit awards covering an aggregate of 14,000 shares of its common stock to two new, non-executive employees to induce them to join the company. The awards were granted under Sonendo's 2023 Employment Inducement Incentive Award Plan (the "Inducement Plan"), which was adopted on March 2, 2023 and provides for the granting of equity awards to prospective employees of Sonendo under NYSE Listing Rule 303A.08. The restricted stock unit awards vest over a four-year p

      9/26/23 8:00:00 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care

    $SONX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mcgaugh John P. bought $11,545 worth of shares (116,500 units at $0.10), increasing direct ownership by 47% to 363,797 units (SEC Form 4)

      4 - Sonendo, Inc. (0001407973) (Issuer)

      5/23/24 6:05:19 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Bergheim Olav bought $49,504 worth of shares (520,000 units at $0.10) (SEC Form 4)

      4 - Sonendo, Inc. (0001407973) (Issuer)

      5/17/24 2:30:11 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Pudipeddi Vamsi Mohan Raj bought $47,000 worth of shares (500,000 units at $0.09), increasing direct ownership by 27% to 2,374,498 units (SEC Form 4)

      4 - Sonendo, Inc. (0001407973) (Issuer)

      5/14/24 5:18:33 PM ET
      $SONX
      Medical/Dental Instruments
      Health Care

    $SONX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sonendo downgraded by Stifel

      Stifel downgraded Sonendo from Buy to Hold

      3/12/24 7:33:34 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Morgan Stanley initiated coverage on Sonendo with a new price target

      Morgan Stanley initiated coverage of Sonendo with a rating of Equal-Weight and set a new price target of $6.90

      1/31/22 7:34:46 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care
    • Stifel initiated coverage on Sonendo with a new price target

      Stifel initiated coverage of Sonendo with a rating of Buy and set a new price target of $16.00

      11/23/21 7:43:50 AM ET
      $SONX
      Medical/Dental Instruments
      Health Care